Log on / register
Feedback | Support | My details

Comments

Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor

Jennifer P Montgomery email and Paul H Patterson email

BMC Cancer 2008, 8:354doi:10.1186/1471-2407-8-354

No comments have yet been made on this article

Post a comment


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.